139 related articles for article (PubMed ID: 26538442)
1. An association of losartan-hydrochlorothiazide, but not losartan-furosemide, completely arrests progressive injury in the remnant kidney.
Arias SC; Souza RA; Malheiros DM; Fanelli C; Fujihara CK; Zatz R
Am J Physiol Renal Physiol; 2016 Jan; 310(2):F135-43. PubMed ID: 26538442
[TBL] [Abstract][Full Text] [Related]
2. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model.
Fujihara CK; Malheiros DM; Zatz R
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1810-8. PubMed ID: 17344184
[TBL] [Abstract][Full Text] [Related]
3. Regression of albuminuria and hypertension and arrest of severe renal injury by a losartan-hydrochlorothiazide association in a model of very advanced nephropathy.
Arias SC; Valente CP; Machado FG; Fanelli C; Origassa CS; de Brito T; Camara NO; Malheiros DM; Zatz R; Fujihara CK
PLoS One; 2013; 8(2):e56215. PubMed ID: 23431367
[TBL] [Abstract][Full Text] [Related]
4. An extremely high dose of losartan affords superior renoprotection in the remnant model.
Fujihara CK; Velho M; Malheiros DM; Zatz R
Kidney Int; 2005 May; 67(5):1913-24. PubMed ID: 15840039
[TBL] [Abstract][Full Text] [Related]
5. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation.
Fanelli C; Fernandes BH; Machado FG; Okabe C; Malheiros DM; Fujihara CK; Zatz R
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F580-7. PubMed ID: 21653629
[TBL] [Abstract][Full Text] [Related]
6. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
Gonçalves AR; Fujihara CK; Mattar AL; Malheiros DM; Noronha Ide L; de Nucci G; Zatz R
Am J Physiol Renal Physiol; 2004 May; 286(5):F945-54. PubMed ID: 15075190
[TBL] [Abstract][Full Text] [Related]
7. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
[TBL] [Abstract][Full Text] [Related]
8. Early brief treatment with losartan plus mycophenolate mofetil provides lasting renoprotection in a renal ablation model.
Fujihara CK; Vieira JM; Sena CR; Ventura BH; Malheiros DM; Zatz R
Am J Nephrol; 2010; 32(2):95-102. PubMed ID: 20551627
[TBL] [Abstract][Full Text] [Related]
9. Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney.
Fujihara CK; DE Lourdes Noronha I; Malheiros DMAC; Antunes GR; DE Oliveira IB; Zatz R
J Am Soc Nephrol; 2000 Feb; 11(2):283-290. PubMed ID: 10665935
[TBL] [Abstract][Full Text] [Related]
10. Influence of differing classes of antihypertensive agents on mesangial kinetics following partial renal ablation in rats.
Odum J; Purkiss J; Naish PF
Nephrol Dial Transplant; 1994; 9(2):131-7. PubMed ID: 8190327
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension.
Dussol B; Moussi-Frances J; Morange S; Somma-Delpero C; Mundler O; Berland Y
Nephrol Dial Transplant; 2005 Feb; 20(2):349-53. PubMed ID: 15615808
[TBL] [Abstract][Full Text] [Related]
12. Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model.
Fujihara CK; Antunes GR; Mattar AL; Malheiros DM; Vieira JM; Zatz R
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F92-9. PubMed ID: 16896182
[TBL] [Abstract][Full Text] [Related]
13. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
Zhou X; Matavelli LC; Ono H; Frohlich ED
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
[TBL] [Abstract][Full Text] [Related]
14. Mechanism underlying the efficacy of combination therapy with losartan and hydrochlorothiazide in rats with salt-sensitive hypertension.
Yamada Y; Tsuboi K; Hattori T; Murase T; Ohtake M; Furukawa M; Ueyama J; Nishiyama A; Murohara T; Nagata K
Hypertens Res; 2011 Jul; 34(7):809-16. PubMed ID: 21471973
[TBL] [Abstract][Full Text] [Related]
15. A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy.
Fujihara CK; Kowala MC; Breyer MD; Sena CR; Rodrigues MV; Arias SCA; Fanelli C; Malheiros DM; Jadhav PK; Montrose-Rafizadeh C; Krieger JE; Zatz R
Sci Rep; 2017 Aug; 7(1):7899. PubMed ID: 28801620
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor blockade blocker pre-treatment largely prevents injury from gradual renal ablation in rats.
Park HW; Kim Y; Kim KH; Jeong HJ; Shin MH; Rozen S; Mauer M
J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):110-7. PubMed ID: 17907098
[TBL] [Abstract][Full Text] [Related]
17. Chronic administration of furosemide augments renal weight and glomerular capillary pressure in normal rats.
Lane PH; Tyler LD; Schmitz PG
Am J Physiol; 1998 Aug; 275(2):F230-4. PubMed ID: 9691012
[TBL] [Abstract][Full Text] [Related]
18. Furosemide compared with hydrochlorothiazide. Long-term treatment of hypertension.
Araoye MA; Chang MY; Khatri IM; Freis ED
JAMA; 1978 Oct; 240(17):1863-6. PubMed ID: 357764
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Lebel M; Rodrigue ME; Agharazii M; Larivière R
Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the effects of hydrochlorothiazide and indapamide on the kidney in hypertensive patients inadequately controlled with losartan.
Wang S; Li J; Zhou X; Liu K; Zhang X; Meng Q; Shi R; Shi D; Chen X
J Hum Hypertens; 2017 Dec; 31(12):848-854. PubMed ID: 28703124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
